blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4023219

EP4023219 - NANOEMULSION OF 18BETA-GLYCYRRHETINIC ACID [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  05.07.2024
Database last updated on 03.10.2024
FormerRequest for examination was made
Status updated on  03.06.2022
FormerThe international publication has been made
Status updated on  12.02.2021
Most recent event   Tooltip27.08.2024New entry: Application deemed to be withdrawn: despatch of communication + time limit 
Applicant(s)For all designated states
Atso Corporate Affairs, S.A. De C.V.
Meseta No. 232, Col. Jardines del Pedregal
Coidad de Mexico, 01900 / MX
[2022/27]
Inventor(s)01 / ZENDEJAS HERNÁNDEZ, Ulises
Segunda Cerrada de Olmecas S/N
Santa Cruz Tlapacoya
Ciudad de México, 56570 / MX
 [2022/27]
Representative(s)Pons
Glorieta Rubén Darío 4
28010 Madrid / ES
[2022/27]
Application number, filing date20849613.307.08.2020
[2022/27]
WO2020MX50025
Priority number, dateMX2019000948208.08.2019         Original published format: MX 2019009482
[2022/27]
Filing languageES
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021025550
Date:11.02.2021
Language:ES
[2021/06]
Type: A1 Application with search report 
No.:EP4023219
Date:06.07.2022
Language:EN
[2022/27]
Search report(s)International search report - published on:ES11.02.2021
(Supplementary) European search report - dispatched on:EP24.03.2023
ClassificationIPC:A61K31/19, A61K9/107, B82Y5/00, A61K9/06, A61K9/08, A61K47/10
[2023/17]
CPC:
A61K31/19 (EP,US); A61K47/10 (EP,US); A61K47/44 (US);
A61K9/06 (EP,US); A61K9/08 (EP); A61K9/1075 (EP,US);
A61P35/00 (US); B82Y5/00 (EP) (-)
Former IPC [2022/27]A61K31/19, A61K9/107, B82Y5/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/27]
Validation statesKH04.03.2022
MA04.03.2022
MD04.03.2022
TN04.03.2022
TitleGerman:NANOEMULSION VON 18BETA-GLYCYRRHETINSÄURE[2022/27]
English:NANOEMULSION OF 18BETA-GLYCYRRHETINIC ACID[2022/27]
French:FORMES PHARMACEUTIQUES DE L'ACIDE18BETA-GLYCYRRHÉTINIQUE[2022/27]
Entry into regional phase04.03.2022Translation filed 
04.03.2022National basic fee paid 
04.03.2022Search fee paid 
04.03.2022Designation fee(s) paid 
04.03.2022Examination fee paid 
Examination procedure04.03.2022Examination requested  [2022/27]
10.10.2023Amendment by applicant (claims and/or description)
10.10.2023Date on which the examining division has become responsible
08.07.2024Invitation to indicate the basis for amendments (Time limit: M01)
26.08.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
Fees paidRenewal fee
04.03.2022Renewal fee patent year 03
02.08.2023Renewal fee patent year 04
07.08.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US4424204  (MINAMINO HIROMI [JP], et al);
 [X]EP0243248  (PHARMA ROCHE POSAY LAB [FR], et al);
 [X]CN105342987  (YAFEI SHANGHAI BIOLOG MEDICINE SCIENCE & TECHNOLOGY CO LTD);
 [X]ITUB20159218  (VALITUDO PHARMA SRLS)
International search[Y]MX2011002098  (DESARROLLOS VPH S A DE C V [MX]) [Y] 25,26 * , the whole document *;
 [A]RU2493852  (KLOPOTENKO LEONID LEONIDOVICH [RU]) [A] 19-22, 25, 26 * , the whole document *;
 [Y]WO2019039931  (ATSO CORP AFFAIRS S A DE C V [MX]) [Y] 25,26 * , the whole document *;
 [XY]  - PUGLIA C. et al., "Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: Characterization and in vitro and in vivo evaluation", Drug Delivery, (20100802), vol. 17, no. 3, pages 123 - 129, XP055791292 [X] 19-22 * the whole document * [Y] 25,26

DOI:   http://dx.doi.org/10.3109/10717540903581679
 [XY]  - Mishra, Moumita; Shegokar, Ranjita; Gohla, Sven; Muller, Rainer H., "Improved skin penetration of hydrophobic Glycyrrhetinic Acid SmartCrystal@ compared to its water soluble salt", Drug Delivery Letters, (20171201), vol. 7, no. 3, doi:10.2174/2210303107666170929115817, ISSN 2210-3031, pages 211 - 218, XP055902282 [X] 19-22 * , the whole document * [Y] 25,26

DOI:   http://dx.doi.org/10.2174/2210303107666170929115817
 [A]  - Hong-Mei Zhuang,Xiao Hu,Shu-Rong Hong,Ping-Ping Zhou, Yu Zhang ,Ling Li, "18a-Glycyrrhetinic acid inhibits the viability of HR 5-CL11 cervical carcinoma cells through induction of apoptosis and DNA damage", Bangladesh J Pharmacol, (20160826), vol. 11, no. 3, doi:10.3329/bjp.v11i3.26592 , ISSN 1991-0088, pages 750 - 755, XP055902283 [A] 19-22, 25, 26 * , the whole document *

DOI:   http://dx.doi.org/10.3329/bjp.v11i3.26592
by applicant   - HAO J. et al., Int J. Pharmaceut., (20100000), vol. 399, pages 102 - 108
    - LI, S. et al., Drug Dev. Ind. Pharm., (20120000), vol. 38, pages 855 - 865
    - S. LI et al., "Medium: PBS 7.4 Speed: 280 rpm", Skin Pharmacol Physiol, (20120000), vol. 25, pages 257 - 268
    - PUGLIA C. et al., "Medium: Ethanol-Water (50:50) Speed: 500 rpm", Drug delivery, (20100000), vol. 17, no. 3, pages 123 - 129
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.